慢性阻塞性肺疾病中BODE评分的临床价值

目的比较BODE评分及第一秒用力呼气容积(FEV1)在慢性阻塞性肺疾病(COPD)患者临床评价中的作用。方法对2006年9月~2008年2月医院就诊的4l例稳定期COPD患者FEV1、BODE评分、COPD急性加重(AECOPD)次数、AECOPD持续时间、因AECOPD的住院次数、住院时间及住院时痰培养阳性率进行测定,采用SPSS11.0统计软件进行统计分析。结果FEV1≥1L组及BODE评分<5分组,AECOPD次数、AECOPD持续时间、因AECOPD的住院次数、住院时间及住院时痰培养阳性率,均好于FEV1

ABOUT BODE SCORE OF 41 CASES CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ITS RELATION TO DISEASE SEVERITY

Objective To compare FEV1 with BODE in evaluating COPD. Method Forty - one stable COPD patients,23 males and 18 females, with mean age of 58.8 years,were evaluated for FEV1 and BODE scores, the number duration of acute exacer- bations of COPD （ AECOPD）, number of admissions and duration of hospitalization caused by AECOPD, and sputum culture. All data were statistically analyzed with SPSS 11.0 for Windows. Result There was a remarkable difference in disease severity between the group with FEV1 〉11 L and BODE score 〈5 and the group with FEV1 〈 1 L and BODE score≥5 ,in regard to AECOPD duration and number of attacks, number of admissions,length of hospitalization and positive sputum cultures ,p 〈 0.05. FEV1 had a negative correlation, while BODE SCore had a positive correlation with the above -mentioned parameters ,p 〈 0.01. Conclusion Both FEV1 and BODE score can be used to evaluate disease severity in COPD, however, BODE score is better.